Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Major pharmaceutical companies, including AstraZeneca, Pfizer, and Gilead, have made public their findings on new cancer treatments.

by Team Small News | Jun 4, 2025 | Pfizer, Pharma

The American Society of Clinical Oncology (ASCO) annual meeting was held in Chicago, featuring over 5,000 research abstracts on various cancer treatments and studies. Several pharmaceutical giants and biotech companies presented promising data, including AstraZeneca,...

Nomura elevates price target for Fortis Healthcare, retains ‘buy’ rating, reports Medical Buyer

by Team Small News | Jun 2, 2025 | Fortis, Pharma

Nomura, a research firm, has revised its price target for Fortis Healthcare from Rs 700 to Rs 820, while maintaining its “buy” rating. The firm attributes this increase to the company’s strong growth prospects, driven by its existing infrastructure...

Glenmark Pharmaceuticals’ (NSE:GLENMARK) financial results appear less impressive upon closer examination.

by Team Small News | Jun 2, 2025 | Glenmark, Pharma

Glenmark Pharmaceuticals’ latest earnings report may appear impressive at first glance, but a closer examination reveals some underlying weaknesses. The company’s net profit increased by 15.6% year-over-year, reaching ₹2.16 billion, and revenue grew by...
Sun Pharmaceutical Industries plans to allocate $100 million for the commercialisation of its specialty products during the current fiscal year.

Sun Pharmaceutical Industries plans to allocate $100 million for the commercialisation of its specialty products during the current fiscal year.

by Team Small News | Jun 1, 2025 | Pharma, Sun Pharma

Sun Pharmaceutical Industries, a leading drug manufacturer, has announced plans to invest $100 million in the current fiscal year to commercialize innovative products, with a focus on strengthening its specialty business. The investment will be used to launch two new...
Next-gen leaders are revitalizing India’s pharmaceutical landscape as family-run drug empires successfully navigate leadership transitions.

Next-gen leaders are revitalizing India’s pharmaceutical landscape as family-run drug empires successfully navigate leadership transitions.

by Team Small News | Jun 1, 2025 | Lupin, Pharma, Sun Pharma, Torrent Pharma

India’s largest pharmaceutical companies, such as Sun Pharmaceutical Industries Ltd and Torrent Pharmaceuticals Ltd, are preparing the next generation of their promoter families to take over the reins. Recently, Torrent Pharma announced the appointment of Aman...

Pfizer-Arvinas treatment outperforms AstraZeneca’s in slowing breast cancer progression.

by Team Small News | Jun 1, 2025 | Pfizer, Pharma

A promising experimental treatment for breast cancer, developed by Pfizer and Arvinas, has shown significant results in delaying the progression of the disease. The treatment, called vepdegestrant, was tested in a clinical trial of 624 patients with a specific type of...
« Older Entries
Next Entries »

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress